Article may be outdated

This article is 9 days old. Some details may have changed since publication.

European Medical Journal·4 min read·hard

EULAR 2026 Interview: Antoni Chan

H
Helena Spicer
EULAR 2026 Interview: Antoni Chan
AI Summary

Antoni Chan discusses the implementation of the RheumACaN program, which aims to improve the early diagnosis and referral of inflammatory arthritis. The program combines clinician education with pathway redesign to ensure faster patient access to disease-modifying antirheumatic drugs.

Elaine Dennison University of Reading; Royal Berkshire NHS Foundation Trust, Reading, UK

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in